Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.
Voxel S.A. (VOX) - Total Liabilities
Latest total liabilities as of September 2025: zł286.16 Million PLN
Based on the latest financial reports, Voxel S.A. (VOX) has total liabilities worth zł286.16 Million PLN as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Voxel S.A. - Total Liabilities Trend (2010–2024)
This chart illustrates how Voxel S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Voxel S.A. Competitors by Total Liabilities
The table below lists competitors of Voxel S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vuzix Corp Cmn Stk
NASDAQ:VUZI
|
USA | $4.59 Million |
|
Chien Kuo Construction Co Ltd
TW:5515
|
Taiwan | NT$4.16 Billion |
|
Biodyne Co. Ltd.
KQ:314930
|
Korea | ₩774.37 Million |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
China | CN¥820.25 Million |
|
Ganesha Ecosphere Limited
NSE:GANECOS
|
India | ₹7.72 Billion |
|
Tracsis plc
PINK:TCIIF
|
USA | $32.96 Million |
|
Isabella Bank Corporation
OTCQX:ISBA
|
USA | $2.03 Billion |
|
Galectin Therapeutics Inc
NASDAQ:GALT
|
USA | $138.17 Million |
Liability Composition Analysis (2010–2024)
This chart breaks down Voxel S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Voxel S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Voxel S.A. (2010–2024)
The table below shows the annual total liabilities of Voxel S.A. from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | zł272.80 Million | +16.77% |
| 2023-12-31 | zł233.63 Million | +4.56% |
| 2022-12-31 | zł223.44 Million | -15.53% |
| 2021-12-31 | zł264.52 Million | +2.91% |
| 2020-12-31 | zł257.05 Million | +41.13% |
| 2019-12-31 | zł182.14 Million | +30.96% |
| 2018-12-31 | zł139.07 Million | +28.07% |
| 2017-12-31 | zł108.59 Million | +1.74% |
| 2016-12-31 | zł106.74 Million | +5.68% |
| 2015-12-31 | zł101.00 Million | -9.41% |
| 2014-12-31 | zł111.49 Million | +4.67% |
| 2013-12-31 | zł106.51 Million | +25.63% |
| 2012-12-31 | zł84.78 Million | -29.29% |
| 2011-12-31 | zł119.91 Million | +20.05% |
| 2010-12-31 | zł99.88 Million | -- |